Pulmonary arterial hypertension (PAH) is a dreaded complication of systemic sclerosis (SSc)
that occurs in∼ 10% of patients. Most individuals present with severe symptoms, significant …

Systemic sclerosis is a rare acquired systemic disease characterised by heterogeneous
evolution and outcome. Each year novel insights into the pathogenesis, diagnosis and …

Polycythemia and pulmonary hypertension are 2 human diseases for which better therapies
are needed. Upregulation of hypoxia-inducible factor-2α (HIF-2α) and its target genes …

Background: Systemic sclerosis (SSc) is a rare connective tissue disease that can affect
different organs and has extremely heterogenous presentations. This complexity makes it …

Objectives To evaluate methods of identifying patients with systemic sclerosis (SSc) using
International Classification of Diseases, Tenth Revision (ICD-10) codes (M34*), electronic …

Objectives To develop a prediction model to guide annual assessment of systemic sclerosis
(SSc) patients tailored in accordance to disease activity. Methods A machine learning …

Systemic sclerosis (SSc) is a rare disease, with unfavorable clinical course and prognosis,
characterized by progressive multisystemic involvement. SSc associated pulmonary …

BACKGROUND: Pulmonary arterial hypertension (PAH) is a major cause of morbidity and
mortality in patients with systemic sclerosis (SSc). The objective of this study is to describe …

@ 2022 Nina Marijn van Leeuwen. All right reserved. No part of this study may be
reproduced, stored in a retrival system, or transmitted, in any form or by any means …

Systemic sclerosis (SSc) is a rare disease, with unfavorable clinical course and prognosis,
characterized by progressive multisystemic involvement. SSc associated pulmonary …